Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00054002 · ClinicalTrials.gov registry record · Phase 2
Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma
A Phase 2 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00054002 is a Phase 2 study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 12 participants.
The verdict
NCT00054002, a Phase 2 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill cancer cells. Combining photodynamic therapy with surgery may be an effective treatment for malignant mesothelioma. PURPOSE: Phase II trial to study the effectiveness of combining photodynamic therapy with surgery in treating patients who have malignant mesothelioma.
Interventions
- PROCEDURE conventional surgery
- PROCEDURE adjuvant therapy
- DRUG porfimer sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 1999-03 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00054002
The ClinicalTrials.gov registry entry for NCT00054002 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which conventional surgery is the first listed.
NCT00054002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00054002 about?
NCT00054002 is a clinical study titled "Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma". RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill cancer cells. Combining photodynamic therapy with surgery may be an effective treatment for malignant mesothelioma. PURPOSE: Phase II trial to study the effectiveness of combining photodynami...
What is the current status of trial NCT00054002?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 1999-03. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00054002?
The interventions under investigation include: conventional surgery (PROCEDURE), adjuvant therapy (PROCEDURE), porfimer sodium (DRUG).
Who is sponsoring clinical trial NCT00054002?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.